Cargando…

Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources

The assessment of the duration of pharmacological prescriptions is an important phase in pharmacoepidemiologic studies aiming to investigate persistence, effectiveness or safety of treatments. The Sessa Empirical Estimator (SEE) is a new data-driven method which uses k-means algorithm for computing...

Descripción completa

Detalles Bibliográficos
Autores principales: Pazzagli, Laura, Liang, David, Andersen, Morten, Linder, Marie, Khan, Abdul Rauf, Sessa, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012860/
https://www.ncbi.nlm.nih.gov/pubmed/35428827
http://dx.doi.org/10.1038/s41598-022-10144-9
_version_ 1784687880422031360
author Pazzagli, Laura
Liang, David
Andersen, Morten
Linder, Marie
Khan, Abdul Rauf
Sessa, Maurizio
author_facet Pazzagli, Laura
Liang, David
Andersen, Morten
Linder, Marie
Khan, Abdul Rauf
Sessa, Maurizio
author_sort Pazzagli, Laura
collection PubMed
description The assessment of the duration of pharmacological prescriptions is an important phase in pharmacoepidemiologic studies aiming to investigate persistence, effectiveness or safety of treatments. The Sessa Empirical Estimator (SEE) is a new data-driven method which uses k-means algorithm for computing the duration of pharmacological prescriptions in secondary data sources when this information is missing or incomplete. The SEE was used to compute durations of exposure to pharmacological treatments where simulated and real-world data were used to assess its properties comparing the exposure status extrapolated with the method with the “true” exposure status available in the simulated and real-world data. Finally, the SEE was also compared to a Researcher-Defined Duration (RDD) method. When using simulated data, the SEE showed accuracy of 96% and sensitivity of 96%, while when using real-world data, the method showed sensitivity ranging from 78.0 (nortriptyline) to 95.1% (propafenone). When compared to the RDD, the method had a lower median sensitivity of 2.29% (interquartile range 1.21–4.11%). The SEE showed good properties and may represent a promising tool to assess exposure status when information on treatment duration is not available.
format Online
Article
Text
id pubmed-9012860
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90128602022-04-18 Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources Pazzagli, Laura Liang, David Andersen, Morten Linder, Marie Khan, Abdul Rauf Sessa, Maurizio Sci Rep Article The assessment of the duration of pharmacological prescriptions is an important phase in pharmacoepidemiologic studies aiming to investigate persistence, effectiveness or safety of treatments. The Sessa Empirical Estimator (SEE) is a new data-driven method which uses k-means algorithm for computing the duration of pharmacological prescriptions in secondary data sources when this information is missing or incomplete. The SEE was used to compute durations of exposure to pharmacological treatments where simulated and real-world data were used to assess its properties comparing the exposure status extrapolated with the method with the “true” exposure status available in the simulated and real-world data. Finally, the SEE was also compared to a Researcher-Defined Duration (RDD) method. When using simulated data, the SEE showed accuracy of 96% and sensitivity of 96%, while when using real-world data, the method showed sensitivity ranging from 78.0 (nortriptyline) to 95.1% (propafenone). When compared to the RDD, the method had a lower median sensitivity of 2.29% (interquartile range 1.21–4.11%). The SEE showed good properties and may represent a promising tool to assess exposure status when information on treatment duration is not available. Nature Publishing Group UK 2022-04-15 /pmc/articles/PMC9012860/ /pubmed/35428827 http://dx.doi.org/10.1038/s41598-022-10144-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Pazzagli, Laura
Liang, David
Andersen, Morten
Linder, Marie
Khan, Abdul Rauf
Sessa, Maurizio
Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources
title Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources
title_full Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources
title_fullStr Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources
title_full_unstemmed Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources
title_short Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources
title_sort rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012860/
https://www.ncbi.nlm.nih.gov/pubmed/35428827
http://dx.doi.org/10.1038/s41598-022-10144-9
work_keys_str_mv AT pazzaglilaura rationaleandperformancesofadatadrivenmethodforcomputingthedurationofpharmacologicalprescriptionsusingsecondarydatasources
AT liangdavid rationaleandperformancesofadatadrivenmethodforcomputingthedurationofpharmacologicalprescriptionsusingsecondarydatasources
AT andersenmorten rationaleandperformancesofadatadrivenmethodforcomputingthedurationofpharmacologicalprescriptionsusingsecondarydatasources
AT lindermarie rationaleandperformancesofadatadrivenmethodforcomputingthedurationofpharmacologicalprescriptionsusingsecondarydatasources
AT khanabdulrauf rationaleandperformancesofadatadrivenmethodforcomputingthedurationofpharmacologicalprescriptionsusingsecondarydatasources
AT sessamaurizio rationaleandperformancesofadatadrivenmethodforcomputingthedurationofpharmacologicalprescriptionsusingsecondarydatasources